Picture of HealthEquity logo

HQY HealthEquity Income Statement

0.000.00%
us flag iconLast trade - 00:00
TechnologyBalancedLarge CapHigh Flyer

Annual income statement for HealthEquity, fiscal year end - January 31st, USD millions except per share, conversion factor applied.

2019
January 31st
2020
January 31st
2021
January 31st
2022
January 31st
2023
January 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue287532734757862
Cost of Revenue
Gross Profit181326415424490
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses210496701796853
Operating Profit77.736.232.9-39.19
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes75.843.24.14-66.7-38.1
Provision for Income Taxes
Net Income After Taxes73.939.78.83-44.3-26.1
Net Income Before Extraordinary Items
Extraordinary Items
Net Income73.939.78.83-44.3-26.1
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income73.939.78.83-44.3-26.1
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS1.171.560.7230.09-0.089